Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Howell

Showing results (71-80 of 742) with videos related to

Pageof 75
Sort By:
Physiotherapy|August 1, 1970
Routine pre-and post-operative physiotherapy. A preliminary trialP J Nichols, B Howell
JAMA|June 19, 2002
Cranberry juice and adhesion of antibiotic-resistant uropathogensAmy B Howell, Betsy Foxman
Cancer Treatment and Research|January 1, 1991
Modulation of the activity of cancer chemotherapeutic agents by dipyridamoleR Goel, S B Howell
Applied Optics|January 12, 2010
Some aspects of the optical estimation of microstructure in fog and cloudS Twomey, H B Howell
Cancer Treatment Reports|May 1, 1987
Multivesicular liposomes containing cytarabine for slow-release Sc administrationS Kim, S B Howell
Toxicology and Applied Pharmacology|January 24, 1998
Molecular mechanisms controlling sensitivity to toxic metal ions in yeastP Perego, S B Howell
Cancer Drug Delivery|January 1, 1985
Daily intraperitoneal administration of cytarabine in a patient with peritoneal mesotheliomaM Markman, S B Howell
Molecular Pharmacology|July 27, 1999
Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatinX Lin, S B Howell
BJOG : an International Journal of Obstetrics and Gynaecology|October 21, 2017
Re: Cranberry capsules to prevent nosocomial urinary tract bacteriuria after pelvic surgery: a randomised controlled trial: Cranberry for prevention of bacteriuria?Henry Botto, Amy B Howell
Molecular Cancer Therapeutics|May 30, 2006
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistanceXinjian Lin, Stephen B Howell
Pageof 75

Showing results (71-80 of 742) with videos related to

Sort By:
Pageof 75
Physiotherapy|August 1, 1970
Routine pre-and post-operative physiotherapy. A preliminary trialP J Nichols, B Howell
JAMA|June 19, 2002
Cranberry juice and adhesion of antibiotic-resistant uropathogensAmy B Howell, Betsy Foxman
Cancer Treatment and Research|January 1, 1991
Modulation of the activity of cancer chemotherapeutic agents by dipyridamoleR Goel, S B Howell
Applied Optics|January 12, 2010
Some aspects of the optical estimation of microstructure in fog and cloudS Twomey, H B Howell
Cancer Treatment Reports|May 1, 1987
Multivesicular liposomes containing cytarabine for slow-release Sc administrationS Kim, S B Howell
Toxicology and Applied Pharmacology|January 24, 1998
Molecular mechanisms controlling sensitivity to toxic metal ions in yeastP Perego, S B Howell
Cancer Drug Delivery|January 1, 1985
Daily intraperitoneal administration of cytarabine in a patient with peritoneal mesotheliomaM Markman, S B Howell
Molecular Pharmacology|July 27, 1999
Effect of loss of DNA mismatch repair on development of topotecan-, gemcitabine-, and paclitaxel-resistant variants after exposure to cisplatinX Lin, S B Howell
BJOG : an International Journal of Obstetrics and Gynaecology|October 21, 2017
Re: Cranberry capsules to prevent nosocomial urinary tract bacteriuria after pelvic surgery: a randomised controlled trial: Cranberry for prevention of bacteriuria?Henry Botto, Amy B Howell
Molecular Cancer Therapeutics|May 30, 2006
DNA mismatch repair and p53 function are major determinants of the rate of development of cisplatin resistanceXinjian Lin, Stephen B Howell
Pageof 75